pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·10h ago·1 min read
save

Mirae raises $5.4M to turn patient texts into data for doctors

As people increasingly turn to AI chatbots for health questions, one startup wants patients to talk to its chatbot about their symptoms, so their doctors can make better treatment decisions. Mirae, which raised a $5.4 ...

Jul 28, 2026·read at Endpoints ↗Neutral

Mirae staff photograph July 28, 2026 09:15 AM EDT Health Tech Ex­clu­sive: Mi­rae rais­es $5.4M to turn pa­tient texts in­to da­ta for doc­tors Ngai Yeung Health Tech Reporter As peo­ple in­creas­ing­ly turn to AI chat­bots for health ques­tions, one start­up wants pa­tients to talk to its chat­bot about their symp­toms, so their doc­tors … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
88 words · retrieved 9h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 4h agoFDA reminds investors about the risks of advisory panelsEndpoints
  • 5h agoJ&J proposes $5.5B talc settlementEndpoints
  • 5h agoFDA offers updated guidance for generics of weight loss blockbustersEndpoints
  • 8h agoOak Hill Bio merges with RA Capital SPAC; InnoCare's TYK2 drug hits in Phase 3Endpoints
  • 8h agoFDA staff say Replimune's melanoma trial failed to prove RP1 worksEndpoints